Evidence map›Paper›PMID 27466180›Full record

ArticleHuman molecular genetics2016

SOX10 regulates an alternative promoter at the Charcot-Marie-Tooth disease locus MTMR2.

Elizabeth A Fogarty, Megan H Brewer, Jose F Rodriguez-Molina, William D Law, Ki H Ma, Noah M Steinberg, John Svaren, Anthony Antonellis

Open access · bronzeAbstract read
In one paragraph

Article in Human molecular genetics, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Elizabeth A FogartyNeuroscience Graduate Program.
Megan H BrewerDepartment of Human Genetics, University of Michigan, Ann Arbor, MI, USA.
Jose F Rodriguez-MolinaCellular and Molecular Pathology (CMP) Program.
William D LawDepartment of Human Genetics, University of Michigan, Ann Arbor, MI, USA.
Ki H MaCellular and Molecular Pathology (CMP) Program.
Noah M SteinbergDepartment of Human Genetics, University of Michigan, Ann Arbor, MI, USA.
John SvarenWaisman Center.
Anthony AntonellisNeuroscience Graduate Program antonell@umich.edu.
University of Michigan–Ann Arbor · USUniversity of Wisconsin–Madison · US

Funding

PREDOCTORAL TRAINING IN GENETICST32GM007544 · NIGMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI MORAN, JOHN V. · 1985 to 2022
$11.3M
Regulation of PMP22 Expression in Peripheral NerveR01NS083841 · NINDS · UNIVERSITY OF WISCONSIN-MADISON · PI SVAREN, JOHN P · 2014 to 2018
$1.6M
Dissection of genetic pathways critical for myelinating Schwann cell developmentR01NS073748 · NINDS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI ANTONELLIS, ANTHONY · 2011 to 2015
$1.5M
NIGMS NIH HHS T32 GM007544NINDS NIH HHS R01 NS073748NINDS NIH HHS R01 NS083841
6 · The paper itself

Abstract

Schwann cells are the myelinating glia of the peripheral nervous system and dysfunction of these cells causes motor and sensory peripheral neuropathy. The transcription factor SOX10 is critical for Schwann cell development and maintenance, and many SOX10 target genes encode proteins required for Schwann cell function. Loss-of-function mutations in the gene encoding myotubularin-related protein 2 (MTMR2) cause Charcot-Marie-Tooth disease type 4B1 (CMT4B1), a severe demyelinating peripheral neuropathy characterized by myelin outfoldings along peripheral nerves. Previous reports indicate that MTMR2 is ubiquitously expressed making it unclear how loss of this gene causes a Schwann cell-specific phenotype. To address this, we performed computational and functional analyses at MTMR2 to identify transcriptional regulatory elements important for Schwann cell expression. Through these efforts, we identified an alternative, SOX10-responsive promoter at MTMR2 that displays strong regulatory activity in immortalized rat Schwann (S16) cells. This promoter directs transcription of a previously unidentified MTMR2 transcript that is enriched in mouse Schwann cells compared to immortalized mouse motor neurons (MN-1), and is predicted to encode an N-terminally truncated protein isoform. The expression of the endogenous transcript is induced in a heterologous cell line by ectopically expressing SOX10, and is nearly ablated in Schwann cells by impairing SOX10 function. Intriguingly, overexpressing the two MTMR2 protein isoforms in HeLa cells revealed that both localize to nuclear puncta and the shorter isoform displays higher nuclear localization compared to the longer isoform. Combined, our data warrant further investigation of the truncated MTMR2 protein isoform in Schwann cells and in CMT4B1 pathogenesis.

Indexed as

AnimalsCharcot-Marie-Tooth DiseaseGene Expression RegulationHeLa CellsHumansMiceMotor NeuronsMutationMyelin SheathPeripheral NervesPromoter Regions, GeneticProtein Tyrosine Phosphatases, Non-ReceptorRatsRegulatory Elements, TranscriptionalSchwann CellsSOXE Transcription FactorsMTMR2 protein, humanProtein Tyrosine Phosphatases, Non-ReceptorSOX10 protein, humanSOXE Transcription Factors

Identifiers

PMID27466180
PMCPMC5291229
OpenAlexW2480652978

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.